This message was sent to ##Email##
|
May 23, 2018 |
| | | |
|
|
|
CAP TODAY
In analyzing cervical tissue, adjunctive use of p16 IHC with H&E-stained slides improves accuracy and sensitivity, according to the results of the Cervical Tissue Adjunctive Analysis study presented by Thomas C. Wright Jr., MD, in a webinar hosted by CAP TODAY and made possible by an educational grant from Roche Diagnostics.
READ MORE
Congratulations to the 2018 Student Presentation Winners!
|
   |
ASCT
ASCT would like to congratulate the winners of this year’s Warren R. Lang award for student interesting case presentations. Each year, ASCT invites currently enrolled cytotechnology students to participate in the ASCT Student Case Presentations program at our annual conference. Up to 10 students are selected to present their case presentation in person. Because we know that not all students can attend the conference, we also invite all students to submit their presentation for a computer loop that is shown during the break time sessions of the conference.
The Warren R. Lang Award was established in 1989 by the ASCT Executive Council in memory of Dr. Warren R. Lang. Dr. Lang was a professor of cytotechnology and medical director of the School of Cytotechnology in the College of Allied Health Sciences of the Thomas Jefferson University in the 1970’s and was later promoted to chair of the department of pathology in 1983. He was a relentless advocate for cytotechnologists, cytology students, and pathology residents and enjoyed teaching immensely.
Currently, students who give case presentations at the Annual Conference are eligible for this award. The first-place winner receives $150 and a one-year membership to the ASCT. The second and third-place winners receive $100 and $50, respectively. The computer presentation winner receives $50 in ASCT Bucks.
This year’s winners:
1st place: Briana Rebmann, METC Program Fort Sam Houston, Texas 2nd place: Ioan Tudor Vladislav,University of Wisconsin-Madison 3rd place: Elizabeth Fisher, Indiana University Computer Presentation Winner: Avrina Ririe, University of California, Los Angeles
Date |
Event |
Location |
More information |
June 20, 2018 |
The Bethesda System for Cervical Cytology — Update and Beyond
|
Your PC |
Patricia G. Tiscornia-Wasserman, MD
Professor of Pathology and Cell Biology
Director of Cytopathology
Columbia University Medical Center
Melville, New York
Details
|
July 2018 |
Milan System for Salivary Gland FNA
|
Your PC |
Esther Diana Rossi, MD, PhD, MIAC Division of Anatomic Pathology and Histology Catholic University “Agostino Gemelli” School of Medicine Rome, Italy
Details
|
Available for 6 months after subscribing |
Quality Assessment Center (QAC) Cell Blocks Basics Workbench
|
Your PC |
Details |
Available for 6 months after subscribing |
Quality Assessment Center (QAC)
Document Control for Cytopathology Workbench
|
Your PC |
Details |
Available for 6 months after subscribing |
Quality Assessment Center (QAC)
The LEAN Cytopathology Laboratory Workbench
|
Your PC |
Details |
May 3 - 5, 2019 |
2019 ASCT Annual Conference
|
San Juan, Puerto Rico |
Details |
CAP TODAY
Hologic has received FDA premarket approval for its Hologic ThinPrep Integrated Imager. The company says the Integrated Imager combines the power of ThinPrep computer-assisted imaging and the ease of dual slide review into a single, automated microscope.
READ MORE
Medscape
Vaccination against the human papillomavirus (HPV) is highly protective against precancerous cervical lesions in adolescents and young women compared with placebo, especially those who are negative for HPV at the time of vaccination, a systematic Cochrane review concludes.
READ MORE
URO Today
The manuscript is timely in that, while the status of HPV infection in oropharyngeal cancer (OPCa) is becoming better defined, and is beginning to modify therapy, the case is not true for penile cancer (PeCa). The latter is much less common and data on clinical and viral interactions far fewer.
READ MORE
Reuters
Vaccines designed to prevent infection with human papillomavirus (HPV) are effective in protecting against pre-cancerous cervical lesions in women, particularly in those vaccinated between age 15 and 26, according to a large international evidence review. The research by scientists at the respected scientific network the Cochrane Review also found no increase in the risk of serious side effects, with rates of around 7 percent reported by both HPV-vaccinated and control groups.
READ MORE
Chicago Tribune
A sea change is occurring among men with low-risk prostate cancer: Increasing numbers are avoiding immediate surgery or radiation and are opting instead for close monitoring of the disease to see whether it worsens.
READ MORE
Medical News Today
Gut microbiota could play a role in the development of colon cancer, a new study reveals. If this is true, then it may, in time, lead to treatments that would arrest the growth of cancerous tumors.
READ MORE
Reuters
Testing advanced lung cancer patients for all of the possible genetic mutations that could be driving their cancer at once is more cost effective than testing for one or a limited number of genes at a time, U.S. researchers reported recently.
READ MORE
|
|
|
|
 7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|